|
Volumn 330, Issue 6012, 2010, Pages 1742-1743
|
CIRM: The good, the bad, and the ugly
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EXPERIMENTAL STUDY;
NEUROLOGY;
BIOTECHNOLOGY;
CLINICAL RESEARCH;
EMBRYONIC STEM CELL;
FUNDING;
HUMAN;
MEDICAL RESEARCH;
PARKINSON DISEASE;
PRIORITY JOURNAL;
QUALITY CONTROL;
REGENERATIVE MEDICINE;
SHORT SURVEY;
STEM CELL;
ECONOMICS;
FINANCIAL MANAGEMENT;
LEGAL ASPECT;
NOTE;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
SALARY AND FRINGE BENEFIT;
STEM CELL RESEARCH;
TRANSLATIONAL RESEARCH;
UNITED STATES;
ACADEMIES AND INSTITUTES;
BIOTECHNOLOGY;
CALIFORNIA;
EMBRYONIC STEM CELLS;
FINANCING, GOVERNMENT;
HUMANS;
RESEARCH SUPPORT AS TOPIC;
SALARIES AND FRINGE BENEFITS;
STEM CELL RESEARCH;
TRANSLATIONAL RESEARCH;
UNITED STATES;
|
EID: 78650659987
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.330.6012.1742 Document Type: Short Survey |
Times cited : (2)
|
References (0)
|